The short version
26 companies supply this market — deep enough that no single failure threatens the supply.
Market view
carboprost tromethamine
39 marketed package NDCs · 26 active manufacturers
Most dispensed: 250 ug/mL · Injection, Solution · #10 vials/carton / 1 ml in 1 vial · 250 ug/mL · Injection, Solution · #10 vial, single-doses/carton / 1 ml in 1 vial, single-dose · 250 ug/mL · Injection, Solution · #1 vial/carton / 1 ml in 1 vial
Same drug class
Other molecules FDA puts in Prostaglandin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- tafluprost opthalmic· 1 maker
- travoprost (isomer free)· 1 maker
- travoprost ophthalmic solution usp, 0.004%· 1 maker
- travoprost ophthalmic solution, 0.004%· 1 maker
- travoprost intracameral· 2 makers
- travoprost ophthalmic· 2 makers
- travoprost ophthalmic solution· 4 makers
- dinoprostone· 7 makers
- tafluprost· 12 makers
- travoprost· 16 makers
- alprostadil· 18 makers
- bimatoprost· 38 makers
Common questions
- Is Carboprost tromethamine in shortage right now?
- No. FDA does not currently list Carboprost tromethamine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Carboprost tromethamine?
- 26 companies have marketed Carboprost tromethamine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.